- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SGLT-2 inhibitors
Total 101313 results
-
Array Biopharma, now a wholly owned subsidiary...WithdrawnNon-Small Cell Lung CancerUnited States
-
Sucampo Pharma Americas, LLCSucampo AG; Sucampo Pharmaceuticals, Inc.CompletedChronic Idiopathic ConstipationUnited States
-
Université Catholique de LouvainNorthern State Medical UniversityCompletedChronic Obstructive Pulmonary DiseaseRussian Federation
-
Dinora, Inc.PharPoint Research, Inc.; Analgesic SolutionsTerminated
-
Hebei Senlang Biotechnology Inc., Ltd.The Second Hospital of Hebei Medical UniversityUnknown
-
VANBIERVLIETCompletedPancreatic Tumor | Endoscopic Ultrasonography | Fine Needle AspirationFrance
-
Teva Branded Pharmaceutical Products R&D, Inc.Terminated
-
Eisai LimitedMerck Sharp & Dohme LLCCompletedHepatocellular Carcinoma (HCC)Italy, Korea, Republic of, Poland, United States, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Israel, Japan, Malaysia, Philippines, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Iconic Therapeutics, Inc.TerminatedChoroidal Neovascularization | Wet Macular DegenerationUnited States
-
Maggie's Pearl, LLCActive, not recruitingPmm2-CDG | Phosphomannomutase 2 Deficiency | Phosphomannomutase 2 Congenital Disorder of Glycosylation | Phosphomannomutase II Congenital Disorder of Glycosylation | Phosphomannomutase II DeficiencyUnited States
-
Grünenthal GmbHCompletedLow Back Pain | Chronic PainAustria, Germany, United Kingdom, Croatia, France, Italy, Poland, Spain, Switzerland
-
Kyorin UniversityCompletedMicroRNA Expression Profile in Human VitreousJapan
-
The Danish Research Centre for Chemical SensitivitiesCompletedMultiple Chemical SensitivityDenmark
-
China Medical University HospitalUnknown
-
Novartis PharmaceuticalsCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes Mellitus (T2DM)Japan
-
Seoul National University Bundang HospitalAstellas Pharma Korea, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
SanofiCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Malaysia, Taiwan
-
Population Health Research InstituteMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusCanada
-
Population Health Research InstituteAstraZenecaCompletedType 2 Diabetes MellitusCanada
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
TakedaCompletedType 2 Diabetes MellitusChina
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
-
University Hospital, Strasbourg, FranceNovartisCompleted
-
University of Alabama at BirminghamTerminatedType 2 Diabetes MellitusUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
NovartisCompletedType 2 Diabetes MellitusTaiwan, Philippines, Italy, Germany, Romania, Hungary, Australia, Korea, Republic of, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Nagaoka Red Cross HospitalKurume UniversityUnknownType 2 Diabetes MellitusJapan
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
TakedaCompleted
-
TakedaCompletedType 2 Diabetes Mellitus
-
GlaxoSmithKlineCompleted
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
PegBio Co., Ltd.RecruitingType 2 Diabetes Mellitus (T2DM)China, Taiwan, Hong Kong
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus (T2DM)
-
University Hospital TuebingenWithdrawn
-
University of LiverpoolAstraZeneca; Clinical Practice Research DatalinkActive, not recruitingType 2 Diabetes MellitusUnited Kingdom
-
TakedaCompletedType 2 Diabetes MellitusKorea, Republic of